1. |
Furie RA, Aroca G, Cascino MD, et al. B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis, 2022, 81(1): 100-107.
|
2. |
Yu C, Li P, Dang X, et al. Lupus nephritis: new progress in diagnosis and treatment. J Autoimmun, 2022, 132: 102871.
|
3. |
Chen X, Kang R, Kroemer G, et al. Ferroptosis in infection, inflammation, and immunity. J Exp Med, 2021, 218(6): e20210518.
|
4. |
Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol, 2019, 12(1): 34.
|
5. |
Marks ES, Bonnemaison ML, Brusnahan SK, et al. Renal iron accumulation occurs in lupus nephritis and iron chelation delays the onset of albuminuria. Sci Rep, 2017, 7(1): 12821.
|
6. |
Wang Z, Yin W, Zhu L, et al. Iron drives T helper cell pathogenicity by promoting RNA-binding protein PCBP1-mediated proinflammatory cytokine production. Immunity, 2018, 49(1): 80-92. e7.
|
7. |
Wang W, Lin Z, Feng J, et al. Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis. Lupus, 2022, 31(8): 985-997.
|
8. |
Scindia Y, Wlazlo E, Ghias E, et al. Modulation of iron homeostasis with hepcidin ameliorates spontaneous murine lupus nephritis. Kidney Int, 2020, 98(1): 100-115.
|
9. |
Lee J, Roh JL. SLC7A11 as a gateway of metabolic perturbation and ferroptosis vulnerability in cancer. Antioxidants (Basel), 2022, 11(12): 2444.
|
10. |
Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol, 2019, 23: 101107.
|
11. |
Liu P, Lu Z, Liu L, et al. NOD-like receptor signaling in inflammation-associated cancers: from functions to targeted therapies. Phytomedicine, 2019, 64: 152925.
|
12. |
Chen T, Zhang X, Zhu G, et al. Quercetin inhibits TNF-α induced HUVECs apoptosis and inflammation via downregulating NF-kB and AP-1 signaling pathway in vitro. Medicine (Baltimore), 2020, 99(38): e22241.
|
13. |
Li ST, Dai Q, Zhang SX, et al. Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway. Acta Pharmacol Sin, 2018, 39(8): 1294-1304.
|
14. |
Fitzgerald KA, Kagan JC. Toll-like receptors and the control of immunity. Cell, 2020, 180(6): 1044-1066.
|
15. |
Lu S, Song Y, Luo R, et al. Ferroportin-dependent iron homeostasis protects against oxidative stress-induced nucleus pulposus cell ferroptosis and ameliorates intervertebral disc degeneration in vivo. Oxid Med Cell Longev, 2021, 2021: 6670497.
|
16. |
Wu D, Ai L, Sun Y, et al. Role of NLRP3 inflammasome in lupus nephritis and therapeutic targeting by phytochemicals. Front Pharmacol, 2021, 12: 621300.
|
17. |
Zhao M, Li MY, Gao XF, et al. Downregulation of BDH2 modulates iron homeostasis and promotes DNA demethylation in CD4+ T cells of systemic lupus erythematosus. Clin Immunol, 2018, 187: 113-121.
|
18. |
Piattini F, Matsushita M, Muri J, et al. Differential sensitivity of inflammatory macrophages and alternatively activated macrophages to ferroptosis. Eur J Immunol, 2021, 51(10): 2417-2429.
|
19. |
Kapralov AA, Yang Q, Dar HH, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol, 2020, 16(3): 278-290.
|
20. |
Li P, Jiang M, Li K, et al. Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nat Immunol, 2021, 22(9): 1107-1117.
|
21. |
Liang G, Wolfgang CD, Chen BP, et al. ATF3 gene. Genomic organization, promoter, and regulation. J Biol Chem, 1996, 271(3): 1695-701.
|
22. |
Liu H, Mo H, Yang C, et al. A novel function of ATF3 in suppression of ferroptosis in mouse heart suffered ischemia/reperfusion. Free Radic Biol Med, 2022, 189: 122-135.
|
23. |
Lu S, Wang XZ, He C, et al. ATF3 contributes to brucine-triggered glioma cell ferroptosis via promotion of hydrogen peroxide and iron. Acta Pharmacol Sin, 2021, 42(10): 1690-1702.
|
24. |
Li Y, Yan J, Zhao Q, et al. ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression. Front Pharmacol, 2022, 13: 904314.
|
25. |
Zhao Y, Du Y, Gao Y, et al. ATF3 regulates osteogenic function by mediating osteoblast ferroptosis in type 2 diabetic osteoporosis. Dis Markers, 2022, 2022: 9872243.
|
26. |
Wang Y, Chen D, Xie H, et al. AUF1 protects against ferroptosis to alleviate sepsis-induced acute lung injury by regulating NRF2 and ATF3. Cell Mol Life Sci, 2022, 79(5): 228.
|
27. |
Wu X, Qiu F, Jin X, et al. ATF3: a novel biomarker for the diagnosis of acute kidney injury after cardiac surgery. Ann Transl Med, 2021, 9(22): 1655.
|
28. |
Zhou H, Cheruvanky A, Hu X, et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int, 2008, 74(5): 613-621.
|
29. |
Li G, Zhang J, Liu D, et al. Identification of hub genes and potential ceRNA networks of diabetic nephropathy by weighted gene co-expression network analysis. Front Genet, 2021, 12: 767654.
|
30. |
Zhu B, Ni Y, Gong Y, et al. Formononetin ameliorates ferroptosis-associated fibrosis in renal tubular epithelial cells and in mice with chronic kidney disease by suppressing the Smad3/ATF3/SLC7A11 signaling. Life Sci, 2023, 315: 121331.
|
31. |
Yang Q, Zhang D, Li Y, et al. Paclitaxel alleviated liver injury of septic mice by alleviating inflammatory response via microRNA-27a/TAB3/NF-κB signaling pathway. Biomed Pharmacother, 2018, 97: 1424-1433.
|
32. |
Guo D, Li Q, Lv Q, et al. MiR-27a targets sFRP1 in hFOB cells to regulate proliferation, apoptosis and differentiation. PLoS One, 2014, 9(3): e91354.
|
33. |
Lei S, Chen G, Deng L, et al. Upregulation of miR-27b facilitates apoptosis of TNF-α-stimulated fibroblast-like synoviocytes. Yonsei Med J, 2019, 60(6): 585-591.
|